{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:03:26Z","timestamp":1782846206529,"version":"3.54.5"},"reference-count":64,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>India is set to eliminate tuberculosis (TB) from the country by 2025, 5 years ahead of the global target. Optimizing TB care pathways is challenged by the predominance of private sector care-seeking among symptomatic patients (60%-70%), a setting associated with significant under-notification. To improve the notification of TB among private providers and improve patient management in the private sector, the National Tuberculosis Elimination Program (NTEP), India, has implemented the Patient-Provider Support Agency (PPSA). The PPSA model enables state and district TB units to engage third-party agencies to involve private providers in TB care, providing comprehensive services including diagnosis, notification, and treatment support.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The objective of this study is to assess the cost-effectiveness and feasibility of introducing the PPSA in the National TB elimination program to improve patient management by improving TB case notification, drug-resistant TB case notification, and treatment outcome and reducing loss to follow-up compared to baseline ongoing programs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cohort study will be conducted in 2 parallel groups in the private sector to assess the impact of the PPSA intervention on the primary and secondary outcomes of the NTEP. Eligible patients with TB from the intervention and control district, notified within a defined time frame, will be included. The intervention group will receive all the facilities and benefits under the PPSA model under the NTEP. The control group will receive care under usual conditions. The study will consist of three parts: (1) impact assessment study, (2) cost-effectiveness study, and (3) feasibility and accessibility study. The primary outcomes shall be TB case notification, drug-resistant TB case notification, universal drug susceptibility testing coverage, and treatment outcome. Secondary outcomes shall include the time between the onset of symptoms and treatment initiation, treatment adherence, adverse drug reaction management, improvement in quality of life, and societal costs. Outcome assessments will be done using questionnaires at baseline, after 3 months, at the completion of treatment, and 6 months after the completion of treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study received Institutional ethical approval from Jodhpur School of Public Health Institutional Review Board, India, in accordance with the compliance of Section 4, National Ethical Guidelines for Biomedical and Health Research Involving Human Participants, ICMR (2017), with IRB Number: 10032\/IRB\/20-21. Data collection is underway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our work will add to other implementation studies capturing the role of the private sector in TB care in India. A key strength of this work is its use of detailed patient pathway data from the study site, suggesting that private sector engagement can support TB elimination while improving the quality and coordination of TB services across India\u2019s fragmented health care system.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/76302","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T05:45:08Z","timestamp":1760334308000},"page":"e76302-e76302","source":"Crossref","is-referenced-by-count":0,"title":["Impact and Economic Evaluation of the Patient-Provider Support Agency Model Under India\u2019s National Tuberculosis Elimination Program: Protocol for a Cohort Study"],"prefix":"10.2196","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7889-9739","authenticated-orcid":false,"given":"Nikita","family":"Raula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7734-2856","authenticated-orcid":false,"given":"Ingeborg Maria","family":"van der Putten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4896-758X","authenticated-orcid":false,"given":"Nicole H T M","family":"Dukers-Muijrers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2034-1406","authenticated-orcid":false,"given":"Shankar","family":"Dapkekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8494-5869","authenticated-orcid":false,"given":"Priyakanta","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1026-570X","authenticated-orcid":false,"given":"Silvia M A A","family":"Evers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"issue":"147","key":"R1","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0077-2017","article-title":"Tuberculosis and lung damage: from epidemiology to pathophysiology","volume":"27","author":"Ravimohan","journal-title":"Eur Respir Rev"},{"issue":"suppl_6","key":"R2","doi-asserted-by":"publisher","first-page":"S629","DOI":"10.1093\/infdis\/jix362","article-title":"What we know about tuberculosis transmission: an overview","volume":"216","author":"Churchyard","journal-title":"J Infect Dis"},{"issue":"4","key":"R3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1165\/rcmb.F293","article-title":"The pathogenesis of tuberculosis: the first one hundred (and twenty-three) years","volume":"32","author":"Schluger","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R4","unstructured":"Tuberculosis. World Health Organization. 2021. URL: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tuberculosis [Accessed 25-12-2025]"},{"key":"R5","unstructured":"Global Tuberculosis Report 2022. World Health Organization; 2022. URL: https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2022 [Accessed 25-12-2025]"},{"key":"R6","unstructured":"Tuberculosis India: annual report of the Revised National Tuberculosis Control Programme. Central Tuberculosis Division, Ministry of Health and Family Welfare, Government of India; 2022. URL: https:\/\/tbcindia.mohfw.gov.in\/wp-content\/uploads\/2023\/05\/TBAnnaulReport2022.pdf [Accessed 25-12-2025]"},{"key":"R7","unstructured":"Revised National Tuberculosis Control Programme: National Strategic Plan for Tuberculosis Elimination 2017-2025. Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India; 2017. URL: https:\/\/tbcindia.mohfw.gov.in\/wp-content\/uploads\/2023\/05\/National-Strategic-Plan-2017-25.pdf [Accessed 25-12-2025]"},{"issue":"9","key":"R8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002653","article-title":"Variations in the quality of tuberculosis care in urban India: a cross-sectional, standardized patient study in two cities","volume":"15","author":"Kwan","journal-title":"PLoS Med"},{"issue":"2","key":"R9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191591","article-title":"Diagnostic pathways and direct medical costs incurred by new adult pulmonary tuberculosis patients prior to anti-tuberculosis treatment\u2014Tamil Nadu, India","volume":"13","author":"Veesa","journal-title":"PLoS ONE"},{"issue":"3","key":"R10","doi-asserted-by":"publisher","first-page":"255","DOI":"10.5588\/ijtld.13.0585","article-title":"Delays in diagnosis and treatment of pulmonary tuberculosis in India: a systematic review","volume":"18","author":"Sreeramareddy","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"R11","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/cid\/cir889","article-title":"Totally drug-resistant tuberculosis in India","volume":"54","author":"Udwadia","journal-title":"Clin Infect Dis"},{"issue":"9","key":"R12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024160","article-title":"From where are tuberculosis patients accessing treatment in India? Results from a cross-sectional community based survey of 30 districts","volume":"6","author":"Satyanarayana","journal-title":"PLoS One"},{"issue":"3","key":"R13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001805","article-title":"Testing and treating the missing millions with tuberculosis","volume":"12","author":"Pai","journal-title":"PLoS Med"},{"issue":"3","key":"R14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1093\/trstmh\/trw003","article-title":"TB control: challenges and opportunities for India","volume":"110","author":"Pai","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R15","unstructured":"Notice inviting tender for selection of service providers for working as a patient provider support agency (PPSA) for providing tuberculosis (TB) related services & drug logistic & support chain: Tender reference No. E-49\/DHS\/Proc.Cell\/PPSA\/DL&SC\/2019-20. Directorate of Health Services, Government of Maharashtra; 2018."},{"key":"R16","unstructured":"Standard document for selection of PPSA. Ministry of Health & Family Welfare-Government of India; 2019. URL: https:\/\/tbcindia.mohfw.gov.in\/wp-content\/uploads\/2023\/05\/4862716111Standard-Document-for-Selection-of-PPSA-revised.pdf [Accessed 25-12-2025]"},{"issue":"1","key":"R17","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08396-5","article-title":"Free drug provision for tuberculosis increases patient follow-ups and successful treatment outcomes in the Indian private sector: a quasi experimental study using propensity score matching","volume":"23","author":"Sodhi","journal-title":"BMC Infect Dis"},{"issue":"6","key":"R18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001842","article-title":"Achieving systemic and scalable private sector engagement in tuberculosis care and prevention in Asia","volume":"12","author":"Wells","journal-title":"PLoS Med"},{"issue":"2","key":"R19","first-page":"153","volume":"46","author":"Moghri","journal-title":"Iran J Public Health"},{"issue":"1","key":"R20","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-2064-3","article-title":"Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis","volume":"16","author":"Gomez","journal-title":"BMC Infect Dis"},{"issue":"2","key":"R21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.4103\/jdmimsu.jdmimsu_777_24","article-title":"Assessing the operationalization of patient-provider support agencies supporting the private-sector tuberculosis patients in an eastern Indian state","volume":"20","author":"Samal","journal-title":"J Datta Meghe Inst Med Sci Univ"},{"issue":"9","key":"R22","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.18203\/2394-6040.ijcmph20232703","article-title":"Impact of patient provider support agency on private sector engagement in tuberculosis care in eastern India","volume":"10","author":"Narain","journal-title":"Int J Community Med Public Health"},{"issue":"7","key":"R23","doi-asserted-by":"publisher","first-page":"751","DOI":"10.5588\/ijtld.15.0186","article-title":"Quality of tuberculosis care in India: a systematic review","volume":"19","author":"Satyanarayana","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6","key":"R24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0214928","article-title":"What would it cost to scale-up private sector engagement efforts for tuberculosis care? Evidence from three pilot programs in India","volume":"14","author":"Deo","journal-title":"PLoS One"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2061","article-title":"A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance","volume":"374","author":"Skivington","journal-title":"BMJ"},{"key":"R26","unstructured":"Nanded district\u2014population 2011-2025. Population Census. 2011. URL: https:\/\/www.census2011.co.in\/census\/district\/349-nanded.html [Accessed 25-12-2025]"},{"key":"R27","unstructured":"National Tuberculosis Elimination Programme. Central Tuberculosis Division. 2021. URL: https:\/\/tbcindia.mohfw.gov.in\/ [Accessed 25-12-2025]"},{"key":"R28","unstructured":"Bid (Beed) district\u2014population 2011-2025. Population Census. 2011. URL: https:\/\/www.census2011.co.in\/census\/district\/361-bid.html [Accessed 25-12-2025]"},{"key":"R29","unstructured":"Tuberculosis patient cost surveys: a handbook; World Health Organization; 2017. URL: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/e2ed2136-7bdf-48c5-bfb8-68f074e43b45\/content [Accessed 28-01-2026]"},{"issue":"5","key":"R30","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1177\/0272989X12458348","article-title":"Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6","volume":"32","author":"Briggs","journal-title":"Med Decis Making"},{"issue":"9","key":"R31","doi-asserted-by":"publisher","first-page":"781","DOI":"10.2165\/00019053-200826090-00008","article-title":"Exploring uncertainty in cost-effectiveness analysis","volume":"26","author":"Claxton","journal-title":"Pharmacoeconomics"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2013.08.027","article-title":"Multivariate linear regression with missing values","volume":"796","author":"Beyad","journal-title":"Anal Chim Acta"},{"issue":"1","key":"R33","doi-asserted-by":"publisher","DOI":"10.1177\/23814683211061097","article-title":"Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations","volume":"7","author":"Husereau","journal-title":"MDM Policy & Practice"},{"key":"R34","unstructured":"Drummond MF Torrance GW Stoddart GL Claxton K Sculpher MJ . Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press; 2015. URL: https:\/\/books.google.co.uk\/books?id=lvWACgAAQBAJ [Accessed 01-01-2026] ISBN: 9780199665884"},{"key":"R35","unstructured":"Guidance Document on Partnerships 2019; Government of India, Ministry of Health and Family Welfare, Central TB Division; 2019. URL: https:\/\/tbcindia.mohfw.gov.in\/wp-content\/uploads\/2023\/05\/9531588006Guidance-Doucument-on-Partnerships-RNTCP-2019.pdf [Accessed 25-12-2025]"},{"key":"R36","unstructured":"Foreign exchange rates: U.S. dollar to Indian rupee. Board of Governors of the Federal Reserve System. URL: https:\/\/www.federalreserve.gov\/releases\/h10\/current\/ [Accessed 25-12-2025]"},{"key":"R37","unstructured":"A complete guide on qualitative data analysis. ATLAS.ti. 2023. URL: https:\/\/atlasti.com\/guides\/qualitative-research-guide-part-2\/qualitative-data-analysis [Accessed 25-12-2025]"},{"issue":"1","key":"R38","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1080\/13814788.2017.1375092","article-title":"Series: practical guidance to qualitative research. Part 4: trustworthiness and publishing","volume":"24","author":"Korstjens","journal-title":"Eur J Gen Pract"},{"issue":"33","key":"R39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.46743\/2160-3715\/2013.1477","article-title":"Inquiry into Issues of trustworthiness and quality in narrative studies: a perspective","volume":"18","author":"Loh","journal-title":"Qual Rep"},{"issue":"1","key":"R40","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4091\/iken1991.9.1_123","article-title":"Distribution of QOL scores in the general population: using WHOQOL","volume":"9","author":"Nakane","journal-title":"Medicine and Society"},{"key":"R41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jctube.2019.100121","article-title":"Quality of life with tuberculosis","volume":"17","author":"Aggarwal","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"issue":"2","key":"R42","doi-asserted-by":"publisher","first-page":"385","DOI":"10.4314\/ahs.v15i2.11","article-title":"Illness perceptions and quality of life among tuberculosis patients in Gezira, Sudan","volume":"15","author":"Mohammed","journal-title":"Afr Health Sci"},{"key":"R43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2014.12.045","article-title":"Health status and quality of life in tuberculosis","volume":"32","author":"Brown","journal-title":"Int J Infect Dis"},{"issue":"3","key":"R44","first-page":"127","volume":"55","author":"Unalan","journal-title":"Indian J Tuberc"},{"issue":"2","key":"R45","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1378\/chest.07-1494","article-title":"Health-related quality of life trajectories among adults with tuberculosis: differences between latent and active infection","volume":"133","author":"Marra","journal-title":"Chest"},{"issue":"5","key":"R46","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s11136-013-0571-x","article-title":"Factors associated with health-related quality of life among pulmonary tuberculosis patients in Manila, the Philippines","volume":"23","author":"Masumoto","journal-title":"Qual Life Res"},{"key":"R47","unstructured":"The end TB strategy. World Health Organization; 2015. URL: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/d128ca35-55c7-4ec8-b2f3-987ca112a4a2\/content [Accessed 25-12-2025]"},{"key":"R48","doi-asserted-by":"publisher","DOI":"10.36347\/sjams.2014.v02i06.089","article-title":"Assessment quality of life (QoL) of TB patients registered in tuberculosis units of Ahmedabad municipal corporation area by using WHO short form-36 (SF-36) questionnaire","volume":"2","author":"Patel","journal-title":"Sch J Appl Med Sci"},{"key":"R49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2014.12.004","article-title":"Health-related quality of life as a predictor of tuberculosis treatment outcomes in Iraq","volume":"31","author":"Dujaili","journal-title":"Int J Infect Dis"},{"issue":"6","key":"R50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156258","article-title":"Evaluation of Health-related quality of life among tuberculosis patients in two cities in Yemen","volume":"11","author":"Jaber","journal-title":"PLoS One"},{"issue":"2","key":"R51","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/s0167-6296(01)00130-8","article-title":"The estimation of a preference-based measure of health from the SF-36","volume":"21","author":"Brazier","journal-title":"J Health Econ"},{"issue":"8","key":"R52","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s10198-020-01195-8","article-title":"Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines","volume":"21","author":"Kennedy-Martin","journal-title":"Eur J Health Econ"},{"issue":"5","key":"R53","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10488-013-0528-y","article-title":"Purposeful sampling for qualitative data collection and analysis in mixed method implementation research","volume":"42","author":"Palinkas","journal-title":"Adm Policy Ment Health"},{"issue":"3","key":"R54","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1442-2018.2010.00541.x","article-title":"Recruitment of hard-to-reach population subgroups via adaptations of the snowball sampling strategy","volume":"12","author":"Sadler","journal-title":"Nurs Health Sci"},{"key":"R55","unstructured":"Mandatory notification of TB diagnosis. Knowledge Base for the National TB Elimination Program - NTEP. URL: https:\/\/ntep.in\/node\/361\/CP-mandatory-notification-tb-diagnosis [Accessed 25-12-2025]"},{"key":"R56","unstructured":"Universal drug-susceptibility testing [UDST] for TB. Knowledge Base for the National Tuberculosis Elimination Programme. URL: https:\/\/ntep.in\/node\/1385\/CP-universal-drug-susceptibility-testing-udst-tb [Accessed 25-12-2025]"},{"key":"R57","unstructured":"Nutritional support to TB patients (Nikshay Poshan Yojana). Government of India, Ministry of Health & Family Welfare (Central TB Division); 2018. URL: https:\/\/tbcindia.mohfw.gov.in\/wp-content\/uploads\/2023\/05\/6851513623Nutrition-support-DBT-Scheme-details.pdf [Accessed 25-12-2025]"},{"key":"R58","unstructured":"Diagnostic and treatment delay in tuberculosis: an in-depth analysis of the health-seeking behaviour of patients and health system response in seven countries of the eastern mediterranean region. World Health Organization; 2006. URL: https:\/\/applications.emro.who.int\/dsaf\/dsa710.pdf [Accessed 25-12-2025]"},{"key":"R59","unstructured":"Adherence to long-term therapies: evidence for action. World Health Organization; 2003. URL: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/121c6b73-8651-442f-9560-e3b1d9c8a75c\/content [Accessed 25-12-2025]"},{"key":"R60","unstructured":"Treatment of tuberculosis: guidelines. World Health Organization; 2010. URL: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/05c9871e-852d-493c-99a2-c7b419c90098\/content [Accessed 25-12-2025]"},{"key":"R61","unstructured":"Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. World Health Organization; 2018. URL: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/d68456c8-2a25-419b-83eb-1dc9df1b838f\/content [Accessed 25-12-2025]"},{"key":"R62","unstructured":"WHO policy on collaborative TB\/HIV activities: guidelines for national programmes and other stakeholders. World Health Organization; 2012. URL: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/d38d86fb-a877-471b-88a6-9f62fba35790\/content [Accessed 25-12-2025]"},{"key":"R63","unstructured":"The International Union Against Tuberculosis and Lung Disease. Collaborative framework for care and control of tuberculosis and diabetes. World Health Organization; 2011. URL: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/60acd5ab-701f-41a7-bea4-e24c72eb1806\/content [Accessed 25-12-2025]"},{"issue":"1","key":"R64","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4103\/0970-0218.39249","article-title":"Impact of tuberculosis on the quality of life","volume":"33","author":"Dhuria","journal-title":"Indian J Community Med"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e76302","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:07:47Z","timestamp":1782842867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e76302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":64,"URL":"https:\/\/doi.org\/10.2196\/76302","relation":{},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"article-number":"v15i147e76302"}}